This rigorous analytical validation verifies the precise amino acid sequence layouts, exact molecular weights, and correct spatial conformations while ensuring the total absence of residual synthesis reagents, truncated fragments, heavy metals, or raw contaminants
Current testing status, available Certificates of Analysis, and verification details are maintained on our Third-Party Testing & Certificates of Analysis page
Why We Picked Them: Luis Martinez, MD leads the clinical team
Preferential tissue distribution to kidneys, liver, and gastrointestinal tract aligns with observed therapeutic effects in animal studies
Pal-GHK might inhibit p38 MAPK activation by obstructing the upstream kinases that activate this pathway or interfering with the signaling molecules responsible for its phosphorylation